lunedì, 12 ottobre 2026

Notizie AIOM – anno XVI n. 698

12 Novembre 2018

FDA Approves Pembrolizumab for HCC

November 9, 2018 - The FDA has granted pembrolizumab an accelerated approval for the treatment of patients with hepatocellular carcinoma (HCC) who have previously received sorafenib, according to Merck (MSD), the manufacturer of the PD-1 inhibitor. The approval is based ...
Leggi tutto

12 Novembre 2018

Human medicine European public assessment report (EPAR): Abemaciclib (Eli Lilly)

November 9, 2018 - This Human medicine European public assessment report (EPAR) was updated. Leggi tutto

12 Novembre 2018

Human medicine European public assessment report (EPAR): Bortezomib (Sun)

November 9, 2018 - This Human medicine European public assessment report (EPAR) was updated. Leggi tutto

12 Novembre 2018

Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

It is unclear whether supplementation with vitamin D reduces the risk of cancer or cardiovascular disease, and data from randomized trials are limited. We conducted a nationwide, randomized, placebo-controlled trial, with a two-by-two factorial design, of vitamin D3 (cholecalciferol) ...
Leggi tutto

12 Novembre 2018

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

To determine the activity of pembrolizumab as neoadjuvant immunotherapy before radical cystectomy (RC) for muscle-invasive bladder carcinoma (MIBC) for which standard cisplatin-based chemotherapy is poorly used. In the PURE-01 study, patients had a predominant urothelial ...
Leggi tutto

12 Novembre 2018

Necrologio Arti Hurria

L’intera comunità oncologica, non solo statunitense, piange la scomparsa della dottoressa Arti Hurria, tragicamente scomparsa qualche giorno fa in un incidente stradale negli Stati Uniti. La dottoressa Hurria, membro del Board of Directors dell’ASCO, si ...
Leggi tutto

12 Novembre 2018

Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer

Higher intake of marine n−3 (also called omega-3) fatty acids has been associated with reduced risks of cardiovascular disease and cancer in several observational studies. Whether supplementation with n−3 fatty acids has such effects in general populations at ...
Leggi tutto

12 Novembre 2018

9 novembre 2018 – Intervista a Luca Li Bassi, nuovo DG AIFA

12 Novembre 2018

9 novembre 2018 – Rilascio reportistiche agli utenti regionali dei Registri di Monitoraggio

12 Novembre 2018

Human medicine European public assessment report (EPAR): Filgrastim (Accord)

November 9, 2018 - This Human medicine European public assessment report (EPAR) was updated. Leggi tutto